MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jac/dkaf081

Медицинская библиотека · The Journal of antimicrobial chemotherapy · 2025

A retrospective observational cohort study of oral azithromycin treatment for Legionnaires' disease.

Pairman Lorna, Beh Yong Tai, Maher Hannah, Gardiner Sharon J, Chin Paul, Williman Jonathan, Chambers Stephen T

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Legionnaires' disease (LD) is typically treated with macrolides, including the azalide azithromycin, or quinolones. In 2013, guidelines for empirical treatment of community-acquired pneumonia at Christchurch Hospital, New Zealand were changed to prioritize oral azithromycin over IV clarithromycin.

OBJECTIVES

To determine whether the change in antimicrobial guidelines led to altered outcomes for patients subsequently confirmed to have LD.

METHODS

Patients with confirmed LD between 2010 and 2020 were identified from clinical and laboratory data. Hospital records were used to identify mortality, ICU admission, length of hospital stay, time to clinical stability, and time to first anti-Legionella treatment. Mean differences, risk ratios (RRs) and an interrupted time series with propensity adjustment were used to compare patient outcomes before and after the guideline change.

RESULTS

There were 323 patients included: 128 before and 195 after the change. Patient outcomes generally improved after the change including: mortality within 30 days (RR 0.4, 95% CI 0.2-0.8); ICU admission (RR 0.6, 95% CI 0.5-0.9); length of stay (difference -2.3 days, 95% CI -4.3 to -0.4); and time to clinical stability (difference -2.4 days, 95% CI -4.3 to -0.5). The interrupted time series analysis suggested improvements in patient outcomes may have occurred regardless of the guideline change.

CONCLUSIONS

Outcomes for patients with LD were not worsened by the change in antimicrobial guidelines and may have improved. Overall rates of mortality were low. This result was reassuring given the harm that may result from unnecessary use of IV compared with oral antimicrobial agents.

Для цитирования: Pairman Lorna, Beh Yong Tai, Maher Hannah, Gardiner Sharon J, Chin Paul, Williman Jonathan, Chambers Stephen T. A retrospective observational cohort study of oral azithromycin treatment for Legionnaires' disease.. The Journal of antimicrobial chemotherapy. 2025. DOI: 10.1093/jac/dkaf081.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.